Recent Finacing
Recent Raise
BERTIS develops AI-driven proteomics diagnostics and the NexQ Prot quantitative proteomics platform to improve reproducibility and speed; markets MASTOCHECK blood test for early-stage breast cancer and expands disease pipeline.
Focus Areas
Recent Investors
Valuation as of 12/28/2020
Total Raised
Funding round
Investors
